The Viral Transcription Group Determines the HLA Class I Cellular Immune Response Against Human Respiratory Syncytial Virus*

The cytotoxic T-lymphocyte-mediated killing of virus-infected cells requires previous recognition of short viral antigenic peptides bound to human leukocyte antigen class I molecules that are exposed on the surface of infected cells. The cytotoxic T-lymphocyte response is critical for the clearance of human respiratory syncytial virus infection. In this study, naturally processed viral human leukocyte antigen class I ligands were identified with mass spectrometry analysis of complex human leukocyte antigen-bound peptide pools isolated from large amounts of human respiratory syncytial virus-infected cells. Acute antiviral T-cell response characterization showed that viral transcription determines both the immunoprevalence and immunodominance of the human leukocyte antigen class I response to human respiratory syncytial virus. These findings have clear implications for antiviral vaccine design.

[1]  L. A. Ball,et al.  Phenotypic Consequences of Rearranging the P, M, and G Genes of Vesicular Stomatitis Virus , 1999, Journal of Virology.

[2]  R. Inman,et al.  Immunodominance: a pivotal principle in host response to viral infections. , 2012, Clinical immunology.

[3]  Ed van der Heeft,et al.  Dynamics of measles virus protein expression are reflected in the MHC class I epitope display. , 2003, Molecular immunology.

[4]  L. J. Anderson,et al.  Protective and disease-enhancing immune responses to respiratory syncytial virus. , 1995, The Journal of infectious diseases.

[5]  Anthony W. Purcell,et al.  Kinetics of Antigen Expression and Epitope Presentation during Virus Infection , 2013, PLoS pathogens.

[6]  B. Walker,et al.  Characterization of a Novel Respiratory Syncytial Virus-Specific Human Cytotoxic T-Lymphocyte Epitope , 2000, Journal of Virology.

[7]  S. Varga,et al.  Determining the Breadth of the Respiratory Syncytial Virus-Specific T Cell Response , 2013, Journal of Virology.

[8]  P. Rohrlich,et al.  HLA-B*0702 transgenic, H-2KbDb double-knockout mice: phenotypical and functional characterization in response to influenza virus. , 2003, International immunology.

[9]  Keiji Fukuda,et al.  Mortality associated with influenza and respiratory syncytial virus in the United States. , 2003, JAMA.

[10]  Hans-Georg Rammensee,et al.  Distorted Relation between mRNA Copy Number and Corresponding Major Histocompatibility Complex Ligand Density on the Cell Surface*S , 2007, Molecular & Cellular Proteomics.

[11]  P. Reche,et al.  CD8 T Cell Epitope Distribution in Viruses Reveals Patterns of Protein Biosynthesis , 2012, PloS one.

[12]  N. Shastri,et al.  The final touches make perfect the peptide-MHC class I repertoire. , 2007, Immunity.

[13]  A. S. Juncker,et al.  Systematic Characterisation of Cellular Localisation and Expression Profiles of Proteins Containing MHC Ligands , 2009, PloS one.

[14]  G. Wertz,et al.  Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K, and 1b proteins of respiratory syncytial virus , 1992, Journal of virology.

[15]  J. Yates,et al.  An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database , 1994, Journal of the American Society for Mass Spectrometry.

[16]  C B Hall,et al.  R ESPIRATORY S YNCYTIAL V IRUS AND P ARAINFLUENZA V IRUS , 2001 .

[17]  E. Lorente,et al.  Concerted In Vitro Trimming of Viral HLA-B27-Restricted Ligands by Human ERAP1 and ERAP2 Aminopeptidases , 2013, PloS one.

[18]  F. Lemonnier,et al.  HLA-A2.1–restricted Education and Cytolytic Activity of CD8+ T Lymphocytes from β2 Microglobulin (β2m) HLA-A2.1 Monochain Transgenic H-2Db β2m Double Knockout Mice , 1997, The Journal of experimental medicine.

[19]  M. del-Val,et al.  Multiple proteases process viral antigens for presentation by MHC class I molecules to CD8(+) T lymphocytes. , 2002, Molecular immunology.

[20]  E. Walsh,et al.  Respiratory syncytial virus infection in elderly and high-risk adults. , 2005, The New England journal of medicine.

[21]  A. Rickinson,et al.  CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells , 2005, The Journal of experimental medicine.

[22]  W. Bodmer,et al.  Monoclonal antibody to a human histocompatibility alloantigen, HLA-A2 , 1978, Nature.

[23]  F. Lemonnier,et al.  H‐2 class I knockout, HLA‐A2.1‐transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies , 1999, European journal of immunology.

[24]  J. Sinnott,et al.  Respiratory Syncytial Virus , 1988, Infection Control & Hospital Epidemiology.

[25]  Ilan Beer,et al.  TAP-independent human histocompatibility complex-Cw 1 antigen processing of an HIV envelope protein conserved peptide , 2010 .

[26]  J. Villadangos,et al.  Unusual topology of an HLA-B27 allospecific T cell epitope lacking peptide specificity. , 1994, Journal of immunology.

[27]  N. Shastri,et al.  Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules. , 2002, Annual review of immunology.

[28]  U. Koszinowski,et al.  HIV Envelope Protein Inhibits MHC Class I Presentation of a Cytomegalovirus Protective Epitope1 , 2001, The Journal of Immunology.

[29]  M. Esteban,et al.  The combination of DNA vectors expressing IL-12 + IL-18 elicits high protective immune response against cutaneous leishmaniasis after priming with DNA-p36/LACK and the cytokines, followed by a booster with a vaccinia virus recombinant expressing p36/LACK. , 2003, Microbes and infection.

[30]  D. Busch,et al.  Cross-competition of CD8+ T cells shapes the immunodominance hierarchy during boost vaccination , 2007, The Journal of experimental medicine.

[31]  P. Hofschneider,et al.  Sendai virus gene expression in lytically and persistently infected cells. , 1990, Virology.

[32]  F. Lemonnier,et al.  Role of Metalloproteases in Vaccinia Virus Epitope Processing for Transporter Associated with Antigen Processing (TAP)-independent Human Leukocyte Antigen (HLA)-B7 Class I Antigen Presentation* , 2012, The Journal of Biological Chemistry.

[33]  J. Alexander,et al.  Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. , 1999, The Journal of infectious diseases.

[34]  F. Hayden,et al.  Viral infections in immunocompromised patients: what's new with respiratory viruses? , 2002, Current opinion in infectious diseases.

[35]  F. Lemonnier,et al.  Multiple Viral Ligands Naturally Presented by Different Class I Molecules in Transporter Antigen Processing-Deficient Vaccinia Virus-Infected Cells , 2011, Journal of Virology.

[36]  R. Holman,et al.  Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. , 2001, The Journal of infectious diseases.

[37]  E. Caron,et al.  The MHC class I peptide repertoire is molded by the transcriptome , 2008, The Journal of experimental medicine.

[38]  A. McMichael,et al.  Recognition of HLA-B27 and related antigen by a monoclonal antibody. , 1982, Human immunology.

[39]  M. Ramos,et al.  Unusual viral ligand with alternative interactions is presented by HLA‐Cw4 in human respiratory syncytial virus‐infected cells , 2011, Immunology and cell biology.

[40]  C. Barnstable,et al.  Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis , 1978, Cell.

[41]  M. Tanimoto,et al.  Identification of novel CTL epitopes of CMV-pp65 presented by a variety of HLA alleles. , 2004, Blood.

[42]  A. Goldberg,et al.  Proteolysis and class I major histocompatibility complex antigen presentation , 1999, Immunological reviews.

[43]  T. Tokusumi,et al.  Recombinant Sendai viruses expressing different levels of a foreign reporter gene. , 2002, Virus research.

[44]  H. Rammensee,et al.  Long-Term Immunity against Actual Poxviral HLA Ligands as Identified by Differential Stable Isotope Labeling1 , 2008, The Journal of Immunology.

[45]  Juri Rappsilber,et al.  Microcolumns with self-assembled particle frits for proteomics. , 2002, Journal of chromatography. A.

[46]  H. Rammensee,et al.  SYFPEITHI: database for MHC ligands and peptide motifs , 1999, Immunogenetics.

[47]  H. Luthra,et al.  Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies , 1995, The Journal of experimental medicine.

[48]  C. Wendt,et al.  Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host. , 1995, Seminars in respiratory infections.

[49]  Ilan Beer,et al.  Multiple, Non-conserved, Internal Viral Ligands Naturally Presented by HLA-B27 in Human Respiratory Syncytial Virus-infected Cells* , 2010, Molecular & Cellular Proteomics.

[50]  C. Bangham,et al.  Specific human cytotoxic T cells recognize B-cell lines persistently infected with respiratory syncytial virus. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[51]  S. Barik.  Transcription of human respiratory syncytial virus genome RNA in vitro: requirement of cellular factor(s) , 1992, Journal of virology.